#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic lymphocytic leukaemia recurrent Immune-mediated renal disorder Osteopetrosis Chondrosarcoma metastatic Chronic granulomatous disease Prodromal Alzheimer's disease Angiosarcoma Oesophageal adenocarcinoma stage II Vitamin B12 deficiency Hodgkin's disease recurrent Cholangiosarcoma Measles Bile acid synthesis disorder Fontan procedure Langerhans cell sarcoma More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Diagnostics Haemophilia – Diagnostics Breast angiosarcoma – Trials in Disease Idiopathic pulmonary fibrosis – Diagnostics Chronic granulomatous disease Alexander disease – Treatment Methylmalonic acidaemia – Life with Disease Sjogren’s syndrome Mast cell activation syndrome – Basic Information Primary hyperoxaluria – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Epcoritamab ANGIOTENSIN II Lurbinectedin X-396 Itepekimab Hhalpc MB-CART2219.1 Bempedoic Acid Lapatinib Chlorambucil Bi 1839100 Rbl035.2 Clopidogrel Hydrogen Sulfate SRSD107 GS-4321 Fludrocortisone Dexchlorpheniramine Maleate Gs-1427 ZUNIBERGENE ROCPARVOVEC Gadoquatrane More therapies…

    Learn about Your Condition

    Vomiting Pulmonary embolism Transplant rejection Meningococcal infection Epithelioid sarcoma Postoperative delirium Nodular melanoma Ocular hypertension Pruritus Breast neoplasm Ophthalmoplegia Necrotising myositis Thromboangiitis obliterans Lichenoid keratosis Femur fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Durvalumab with Oleclumab or Monalizumab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Durvalumab
    • Glucose
    • Infliximab
    France Germany Italy Poland Portugal Spain

  • Study on Amlitelimab for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Amlitelimab
    France Germany Hungary Italy Poland Portugal +1

  • Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bemarituzumab
    • Capecitabine
    • Fluorouracil
    Austria Belgium Bulgaria Czechia France Germany +6

  • Study comparing brigatinib alone versus brigatinib with carboplatin and pemetrexed combination as first treatment for patients with advanced ALK-positive lung cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Brigatinib
    • Carboplatin
    • Pemetrexed
    France

  • Study of XXB750 and Drug Combination for Patients with Heart Failure

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Azilsartan Medoxomil
    • Candesartan
    • Captopril
    Bulgaria Czechia Denmark France Germany Hungary +5

  • Study of RO7269162 in people at risk for or with early-stage Alzheimer’s Disease: Effects on brain amyloid buildup

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Florbetaben (18F)
    • Flutemetamol (18F)
    • Ro7269162
    Denmark France Germany Italy Poland Spain

  • Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Oesophageal adenocarcinoma stage II
    • Oesophageal adenocarcinoma stage III
    Investigated Drugs:
    • Nivolumab
    Belgium Czechia Denmark France Germany Ireland +4

  • Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dapagliflozin
    • Zibotentan
    Austria Bulgaria Denmark France Germany Italy +6

  • Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

    Not recruiting

    3 1
    Investigated Diseases:
    • Alopecia areata
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +7

  • Comparing Methotrexate and Tocilizumab for Treating Giant Cell Arteritis in Patients: A Study on Effectiveness and Safety

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Giant cell arteritis
    Investigated Drugs:
    • Folic Acid
    • Methotrexate
    • Prednisone
    France
Previous Page
1 … 36 37 38 39 40 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!